Brief report: Reclassifying SCLC-Y as SMARCA4 deficient malignancies - resolving the controversy
J. Ng, L. Cai, L. Girard…·K. D. Sutherland
The paper reclassifies YAP1-expressing SCLC-Y as SMARCA4-deficient malignancies, showing they lack SCLC features and instead resemble SMARCA4-deficient tumors.